QualityStar® Appoints Dr. Jared Schwartz as Consulting Chief Medical Officer
Omaha, Nebraska (PRWEB) March 20, 2015 -- QualityStar®, an independent quality assurance consortium for Anatomic Pathology, today announced that Dr. Jared Schwartz, has been named the company’s consulting Chief Medical Officer. In his new role, Dr. Schwartz will help expand QualityStar’s outreach to the pathology community and provide medical input, perspective and vision on future needs of pathologists to the executive management team.
“We are honored to have Dr. Schwartz join QualityStar as opportunity to continue his leadership in the pathology community and to apply his passion for quality and technology to improve patient care”, said Mark Spencer, President of QualityStar.
“The pathology community—fueled by demand for increased transparency and efficiency of pathology services—is at a very critical stage. The potential benefits of external quality assurance and analytics for pathologists to improve their proficiency and demonstrate their quality are compelling. In my new role as QualityStar’s Consulting CMO, I see an opportunity to combine my passion for education and technology with my long-standing focus on improving patient care,” Dr. Schwartz added.
Jared N. Schwartz, M.D., Ph.D., F.C.A.P., brings 30 years of pathology expertise to his role as a consulting Chief Medical Officer at QualityStar. He was formerly the Chief Medical Officer for Aperio and Leica Biosystems, and previously served as President of the College of American Pathologists, and Director of Pathology and Laboratory Medicine at Presbyterian Healthcare in Charlotte, North Carolina. He is Board certified in anatomic and clinical pathology with subspecialty boards in medical microbiology and cytopathology. He is a graduate of Duke University Medical School, where he completed his residency and fellowship training, and served as chief resident.
He was appointed to the Clinical Laboratory Improvement Advisory Committee by HHS, and was a co-chair and author of the ASCO/CAP Guidelines on HER2, which was published in the January 2007 editions of the Journal of Clinical Oncology and Archives of Pathology and Laboratory Medicine and was one of authors of ASCO/CAP Guidelines for ER/PR published in Journal of Clinical Oncology and Archives of Pathology and Laboratory Medicine in 2010. He also serves as a Consulting Professor of Pathology Stanford University.
Dr. Schwartz will be avaiable at the Quality Star booth #98 during USCAP’s 104rd Annual Meeting, taking place March 21st through March 27th, 2015 in Boston, Massachusetts.
About QualityStar
QualityStar® is an independent quality assurance consortium and subscription service offering expert confidential third party quality assurance review using innovative analytics to measure diagnostic proficiency in Anatomic Pathology. Approved by the American Board of Pathology (APB) as a MOC QA Level IV program, QualityStar draws on a national network of specialized experts and serves as an impartial alternative to in-house quality assurance. QualityStar’s patent pending service provides an objective methodology, Practice Proficiency Score (PPS), and longitudinal benchmarking for diagnostic professionals to meet On-going Professional Practice Evaluation (OPPE) requirements for Joint Commission. QualityStar goes beyond the standard peer review concept – ultimately to help pathology practices improve their diagnostic proficiency and improve patient care. For more information, visit http://www.qualitystar.net
Kristl Finnes, Prairie Ventures, http://www.prairieventures.net, +1 (651) 253-0739, [email protected]
Share this article